Status:
COMPLETED
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Glaucoma
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The clinical study compares safety and efficacy of MK0507A (dorzolamide 1.0% / timolol 0.5%) with 1) timolol 0.5% and with 2) concomitant therapy with dorzolamide 1.0% / timolol 0.5% in patients with ...
Eligibility Criteria
Inclusion
- Patients with glaucoma and ocular hypertension
Exclusion
- History of ocular surgery within 3 months
- Administration contradiction to timolol and dorzolamide
Key Trial Info
Start Date :
March 12 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 16 2008
Estimated Enrollment :
474 Patients enrolled
Trial Details
Trial ID
NCT00449956
Start Date
March 12 2007
End Date
February 16 2008
Last Update
June 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.